ReviewExperimental physiology2026
Tackling aging and chronic disease: How space exploration and the 'chameleon effect' of pharmaceuticals can lead the way.
Review in Experimental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tackling aging and chronic disease: How space exploration and the 'chameleon effect' of pharmaceuticals can lead the way.Experimental physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A common misconception surrounding space exploration is that humanity's pursuit of interplanetary travel, such as missions to Mars, is an escape from Earth. In reality, this endeavour offers an invaluable opportunity to address critical biomedical challenges here at home. The extreme conditions of space, including microgravity, cosmic radiation and prolonged isolation, create a natural laboratory for studying human biology under stress, allowing us to explore the boundaries of human resilience. These exposures yield key insights into the biology of aging, the accelerated decline of physiological function and the early onset of chronic diseases. Among the organs most susceptible to environmental stress is the kidney, which is at high risk of failure during long-duration spaceflight. Its sensitivity makes it an ideal model for understanding how stress accelerates degeneration, both in space and on Earth. By studying kidney function alongside broader cellular processes, we can illuminate how stress drives aging and chronic disease. This is particularly exemplified by the process of cellular necrosis (unprogrammed cell death), which represents a key central node as recently demonstrated. Necrosis acts upstream of processes like cellular senescence and tissue degeneration, and is the mechanism through which multiple environmental factors erode resilience and drive the progression of chronic diseases like kidney disease. Following this exploration of how stress accelerates biological decline, we examine strategies that may protect against such damage, preventing disease and preserving physiological resilience. Pharmaceuticals, with their ability to modulate physiology transiently, are especially powerful in dynamic, real-world environments where stressors continually change. This 'chameleon effect' of pharmaceuticals offers the potential to uncouple biological trade-offs and enhance adaptive capacity to stress. Understanding these processes in the space environment provides an unprecedented opportunity, difficult to reproduce on Earth, to identify links between exposure and develop targeted interventions to enhance health and resilience on Earth.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.